IL-7Rα gene loci have been shown to carry gain-of-function mutations in a small fraction of patients with BCP-ALL with most of the mutations being associated with concurrent upregulation of TSLPR upregulation and ligand-independent activation of signaling (46). This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.